Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Clinical Chemistry and Laboratory Medicine|June 11, 2023
Recent advances of drugs monitoring in oral fluid and comparison with bloodSara Casati, Maddalena Binda, Paola Dongiovanni, et al.
Ejhaem|June 27, 2025
Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic TechniquesMiriam Longo, Erika Paolini, Marica Meroni, et al.
Frontiers in Nutrition|March 20, 2023
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains valueErika Paolini, Miriam Longo, Marica Meroni, et al.
Hepatology Communications|October 22, 2021
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseMarica Meroni, Miriam Longo, Rosa Lombardi, et al.
International Journal of Oral Science|June 29, 2023
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammationPaola Dongiovanni, Marica Meroni, Sara Casati, et al.
Plos One|November 16, 2017
Notch signaling and progenitor/ductular reaction in steatohepatitisCarola M Morell, Romina Fiorotto, Marica Meroni, et al.
Annals of Hepatology|April 22, 2026
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver diseaseAllen Anthony Laraño, Silvia Palmisano, Deborah Bonazza, et al.
Peptides|April 18, 2021
NDP-MSH treatment recovers marginal lungs during ex vivo lung perfusion (EVLP)Caterina Lonati, Michele Battistin, Daniele E Dondossola, et al.
Annals of Medicine|May 26, 2016
Liver fat accumulation is associated with circulating PCSK9Massimiliano Ruscica, Nicola Ferri, Chiara Macchi, et al.
Ebiomedicine|February 28, 2021
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activationNadia Panera, Marica Meroni, Miriam Longo, et al.
Pageof 8